OCRA News

Our Community Needs YOU | Heroes Highlights

The ovarian cancer community is counting on a hero… and that OCRA Hero could be you!  If you’re looking to do good in 2022, it can be as simple (and fun!) as turning your favorite activity into a fundraiser…

Read on

Study Finds Pfizer-BioNTech COVID-19 Vaccine Safe and Effective for Gynecologic Oncology Patients

A prospective cohort study recently published on Vaccines set out to determine the safety and effectiveness of the Pfizer-BioNTech COVID-19 vaccine for gynecologic cancer patients undergoing chemotherapy treatment around the time of their…

Read on

PARP Inhibitors and Ovarian Cancer

Over the past decade, a new class of drugs called PARP inhibitors have been approved by the Food and Drug Administration (FDA) for use in ovarian cancer…

Read on

The Overview | January 2022

Happy new year! While the temperatures may be chilly for many of us, we hope everyone is keeping warm with renewed hope for a year of progress toward our mission, and a strong sense of community…

Read on

OCRA Awards Two Ovarian Cancer Research Prizes

OCRA is pleased to announce the recipients of two research prizes, selected by members of our Scientific Advisory Committee for their notable contributions to the field of ovarian cancer research and commitment to future discoveries. Dr…

Read on

Commitments to Make in the New Year That Support OCRA

It’s a new year, and there’s no better time to commit to simple actions that can make a big impact! So simple, that they take between one minute and half an hour to complete. Set OCRA as your AmazonSmile charity of choice…

Read on

OCRA-Funded Research Points to Potential for Predicting Ovarian Cancer

New study findings not only reveal where the most common ovarian cancer subtype originates in certain patients, but also point to the future possibility of being able to predict who will get the disease…

Read on

Acupuncture for Pain Management

Finding ways to minimize the pain caused by ovarian cancer can have a major impact on maximizing the quality of life for those dealing with this illness…

Read on

Even More Ways to Stay Connected and Get Support

OCRA is pleased to announce the offering of an additional four groups to our Staying Connected online support group series…

Read on

Hereditary Breast and Ovarian Cancer Syndrome (HBOC)

Hereditary breast and ovarian cancer syndrome, known as HBOC, refers to a predisposition to develop cancer that is passed down through the generations of a family. HBOC is inherited in the form of a harmful mutation, or change, in a gene…

Read on

OCRA Awards Nearly $6.5 Million in Ovarian Cancer Research Grants

More breakthroughs are on the horizon, as OCRA has awarded grants to 22 dedicated scientists at 15 prestigious medical institutions to enable future ovarian cancer discoveries…

Read on

Secondary Cytoreductive Surgery Post-Recurrence Results in Longer Overall Survival

A randomized trial recently showed that patients with an ovarian cancer recurrence who undergo cytoreductive surgery along with chemotherapy show better survival rates than those who only receive chemotherapy…

Read on